Serum neurone-specific enolase and other neuroendocrine markers in lung cancer

European Journal of Cancer

Volumn 30, Issue 5, 1994, Pages 574-576

  Ledermann, J A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE; TUMOR MARKER;

BLOOD LEVEL; HUMAN; LUNG CANCER; NEUROENDOCRINE TUMOR; NOTE; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0028236442     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(94)90519-3     Document Type: Article

References (28)

1. Establishment and identification of small cell lung cancer cell lines having classic and variant features
2. Neurone specific enolase is produced by neuroendocrine tumours
3. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer
4. Serum neuron-specific enolase is a useful tumour marker for small cell lung cancer
5. Tumour markers for predication of survival and monitoring of remission in small cell lung cancer
6. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer
7. Elevated serum creatine kinase BB levels in patients with small cell lung cancer
8. Elevated serum chromogranin A concentrations in small-cell lung carcinoma
9. The antigens of small cell lung cancer
10. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer
11. Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone marrow infiltration
12. Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening
13. Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer
14. Potential utility of serum neuron-specific enolase levels in small cell carinoma of the lung
15. Evaluation of radioimmunoassay for neuron-specific enolase in small cell lung cancer
16. Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer
17. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung
18. Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC)
19. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance
20. Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma
21. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma
22. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers
23. Neural markers in carcinoma of the lung
24. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours
25. The use of neurendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer
26. Prognostic impact of histologic demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma
27. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
28. Clinical characterization of non-small-cell lung cancer tumours showing neuroendocrine differentiation features